This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMER at https://www.zacks.com/ap/OMER Keywords: Omeros, Earnings …
Omeros Corporation (NASDAQ: OMER) stock has been getting battered since its only marketed product stopped getting special treatment from an important government payer. Omidria's imminent decline is troubling, but perhaps the market …
The a Buy rating for OMER is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative …
If the stock closes at or above $8 at expiration this trade will return 19.76% or 22.68% (for comparison purposes only). OMER closed Mar 5, 2018's trading session at $9.68. In the past year, the stock has hit a 52-week low of $8.36 and 52 …
The following are some of the stocks that lost the largest percentage in price today in the pharma/biotech sector. 1. Advaxis Inc. (ADXS) Lost 28.29% to close Thursday's (Feb.22) trading at $1.80. News: The Company has offered to sell …
Shares in Omeros Corp (NASDAQ:OMER) are worth almost double their current value, according to a leading US investment bank, which repeated its 'buy' advice in the wake of a positive ruling on a key drug by European regulators. …